A unifed global genotyping framework of dengue virus serotype-1 for a stratifed coordinated surveillance strategy of dengue epidemics

Published in Microbiology
A unifed global genotyping framework  of dengue virus serotype-1 for a stratifed  coordinated surveillance strategy of dengue  epidemics
Like

Read the paper

BioMed Central
BioMed Central BioMed Central

A unified global genotyping framework of dengue virus serotype-1 for a stratified coordinated surveillance strategy of dengue epidemics - Infectious Diseases of Poverty

Background Dengue is the fastest spreading arboviral disease, posing great challenges on global public health. A reproduceable and comparable global genotyping framework for contextualizing spatiotemporal epidemiological data of dengue virus (DENV) is essential for research studies and collaborative surveillance. Methods Targeting DENV-1 spreading prominently in recent decades, by reconciling all qualified complete E gene sequences of 5003 DENV-1 strains with epidemiological information from 78 epidemic countries/areas ranging from 1944 to 2018, we established and characterized a unified global high-resolution genotyping framework using phylogenetics, population genetics, phylogeography, and phylodynamics. Results The defined framework was discriminated with three hierarchical layers of genotype, subgenotype and clade with respective mean pairwise distances 2–6%, 0.8–2%, and ≤ 0.8%. The global epidemic patterns of DENV-1 showed strong geographic constraints representing stratified spatial-genetic epidemic pairs of Continent-Genotype, Region-Subgenotype and Nation-Clade, thereby identifying 12 epidemic regions which prospectively facilitates the region-based coordination. The increasing cross-transmission trends were also demonstrated. The traditional endemic countries such as Thailand, Vietnam and Indonesia displayed as persisting dominant source centers, while the emerging epidemic countries such as China, Australia, and the USA, where dengue outbreaks were frequently triggered by importation, showed a growing trend of DENV-1 diffusion. The probably hidden epidemics were found especially in Africa and India. Then, our framework can be utilized in an accurate stratified coordinated surveillance based on the defined viral population compositions. Thereby it is prospectively valuable for further hampering the ongoing transition process of epidemic to endemic, addressing the issue of inadequate monitoring, and warning us to be concerned about the cross-national, cross-regional, and cross-continental diffusions of dengue, which can potentially trigger large epidemics. Conclusions The framework and its utilization in quantitatively assessing DENV-1 epidemics has laid a foundation and re-unveiled the urgency for establishing a stratified coordinated surveillance platform for blocking global spreading of dengue. This framework is also expected to bridge classical DENV-1 genotyping with genomic epidemiology and risk modeling. We will promote it to the public and update it periodically. Graphical Abstract

Dengue, caused by dengue virus (DENV) infection and mainly transmitted by Aedes mosquitoes, is now considered the most prevalent arboviral disease in human, and it circulates predominantly in tropical and subtropical regions, with more than half the world’s population at its risk. Dengue was listed in "Ten threats to global health in 2019" by the World Health Organization. 

Urbanization, climate change, and globalization including rising global tourism are re-shaping the phylogeographic structure of virus populations, possibly contributing to a succession of severe viral pandemics as an unprecedented challenge to global public health. To investigate viral dispersion mechanisms in phylogeography and phylodynamics, various analytical methods and general genotyping methods have been developed for more accurate pathogen identification beyond viral species. Recently, the high-resolution genotyping scheme for surveillance manifested itself to be powerful in rapidly tracking the active lineages and transmission chains of SARS-CoV-2. Even though disease burden assessment and prediction using mosquito ecological data and dengue epidemic data have been investigated globally, there is still lack of a systematic scheme for understanding the DENV population structure, dynamics and mechanisms of cross-national, cross-regional, and even cross-continental transmission in a global profile.

Targeting DENV-1 spreading prominently in recent decades, by reconciling all qualified complete E gene sequences of 5003 DENV-1 strains, with the relative epidemiological information confirmed by literature research, from 78 epidemic countries/areas ranging from 1944 to 2018, the present study has established a unified global high-resolution genotyping framework of DENV-1 designating three hierarchical layers of clade, subgenotype and genotype with respective mean pairwise distances (MPDs)≦0.8%, 0.8-2%, and 2-6%.

Global genotyping framework of DENV-1 established based on its population structure, phylogeny, and epidemiology.

Figure 1 of the paper by Li et al.

On the one hand, the global epidemic patterns of DENV-1 showed strong geographic constraints representing stratified spatial-genetic epidemic pairs of Continent-Genotype, Region-Subgenotype and Nation-Clade. Thereby 12 epidemic regions have been identified including: GMS-China, Great Mekong Subregion-China; SEA, Southeast Asia; PHI, Philippines; TWP, Tropical Western Pacific; OCE, Oceania; WAFR, West African Region; RSR, Red Sea Region; SWIO, Southwest Indian Ocean; SASC, South Asia Subcontinent; CNA, Central North America; CAR, Caribbean; and SA, South America, which prospectively facilitates the region-based coordination. As for the pair of the Region-Subgenotype, 92.3% and 71.8% of the 39 designated subgenotypes, with ≥50% and ≥80% isolates respectively, mainly circulated in a single region.

On the other hand, the present study also reminds us to be concerned about the cross-regional and even cross-continental diffusion of DENV-1, which potentially arouse large epidemics, in reference to the stratified spatial-genetic epidemic pairs. For example, several subgenotypes including 5K, 5B, 4F, 5C, 5M and 5N were found spreading across several regions. The cross-regional transmissions were mostly observed in adjacent regions, especially in the regions of Asian or American Continents, but only a few cross-continental transmissions occurred. Collectively, the transmissions of subgenotypes cross countries/regions, on the rise in recent decades, can explain its continuous global expansion to some extent. Therefore, international collaborations based on the framework in promptly pinpointing and periodically updating the hotspots of emerging, transmission, drifting, and replacement of DENV-1 will give rise to cost-effective surveillance strategy for regional and global control of dengue.

In addition, through in-depth explorations of the global transmission pattern of DENV-1 using this framework, we observed that the traditional endemic countries such as Thailand, Vietnam, Indonesia, the Philippines, India, and Brazil apparently displayed as the persisting dominant source centers, while the emerging epidemic countries such as China, Australia, and the USA, where dengue outbreaks were frequently triggered by importation, showed a growing trend of DENV-1 diffusion. Meanwhile, the singletons in subgenotypes (12/41) and clades (63/208) recognized in our study suggest that they may be partially caused by widely deficient surveillance. The probably hidden epidemics were found especially in Africa and India. Then, our framework can be utilized in an accurate daily coordinated surveillance based on the population compositions of its clades and subgenotypes, which is prospectively valuable for hampering the ongoing transition process of epidemic to endemics and addressing the issue of inadequate monitoring. 

The genotyping framework and its utilization in quantitatively assessing DENV-1 epidemics has laid a foundation and re-unveiled the urgency for establishing a stratified coordinated surveillance platform for blocking global spreading of dengue. This framework is moreover expected to bridge classical DENV-1 genotyping with genomic epidemiology and even pathogen-mosquito-disease-associated risk modelling. The authors will promote the public availability to the framework and keep periodic updating of it as well.

Graphical abstract of the paper by Li et al.

https://idpjournal.biomedcentral.com/articles/10.1186/s40249-022-01024-5

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in